Imaging and therapeutic radiopharmaceutical developer Immunomedics reported fiscal third-quarter revenues of $1.8 million, flat compared with revenues of $1.8 million in the third quarter of 1999. The Morris Plains, NJ-based firm was able to slightly trim its net loss during the period (end-March 31), however. Immunomedics had a net loss of $2.8 million, compared with a net loss of $3.3 million in the same period last year.
By AuntMinnie.com staff writers
May 15, 2000
